Serum β-hCG as an Indicator of Recurrence After the Complete Resection of a Malignant Solitary Fibrous Tumor of the Pleura

  • Hiroshi Yabuki
  • , Akira Sakurada
  • , Hiromichi Niikawa
  • , Hirotsugu Notsuda
  • , Chiaki Endo
  • , Yasushi Matsuda
  • , Masafumi Noda
  • , Ryoko Saito
  • , Shinichi Yamashita
  • , Yoichi Arai
  • , Yoshinori Okada

Research output: Contribution to journalArticlepeer-review

Abstract

In solitary fibrous tumors (SFTs) of the pleura, malignant SFTs are uncommon. Although SFTs are known to cause paraneoplastic syndromes through the production of insulin-like growth factor, to the best of our knowledge, the production of beta-human chorionic gonadotropin (β-hCG) has been reported only in 1 case involving a patient with a benign SFT. We herein report the first case of the elevation of β-hCG serum levels associated with a malignant SFT in which the β-hCG serum level became a useful indicator of recurrence after the complete resection of the primary mediastinal lesion.

Original languageEnglish
Pages (from-to)e551-e553
JournalAnnals of Thoracic Surgery
Volume102
Issue number6
DOIs
Publication statusPublished - 01-12-2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Serum β-hCG as an Indicator of Recurrence After the Complete Resection of a Malignant Solitary Fibrous Tumor of the Pleura'. Together they form a unique fingerprint.

Cite this